STEGLUJAN 100 mg/1

Steglujan 100 mg/1 combines ertugliflozin and sitagliptin for managing type 2 diabetes. This oral medication supports blood sugar control as part of a broader treatment plan.

Steglujan 100 mg/1 is a combination of ertugliflozin and sitagliptin, designed to help manage type 2 diabetes. It works by improving insulin sensitivity and reducing glucose absorption in the kidneys. People often ask, 'What is Steglujan used for?' This medication is typically part of a comprehensive diabetes management strategy, which may include diet and exercise.

Common effects of Steglujan 100 mg/1 may include urinary tract infections, genital yeast infections, and low blood sugar. Some users also report nausea or diarrhea. These effects can vary and are not experienced by everyone.

Handle Steglujan 100 mg/1 with care, especially if you have a history of kidney issues or are prone to dehydration. Always follow your healthcare provider's advice regarding its use. Store the medication as directed to maintain its effectiveness.

Steglujan 100 mg/1 may interact with certain medications, including insulin, other diabetes drugs, and diuretics. Alcohol can also affect its performance. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.